The US Food and Drug Administration (FDA) has added bemotrizinol to the list of permitted sunscreen active ingredients, the first update in 20 years. “This is exactly the kind of progress we can achieve when we modernise our processes and apply sound science to regulatory decisions,” said Mike Davis, Acting Director of the FDA Center for Drug Evaluation and Research (CDER). The US FDA is notoriously conservative when it comes to sunscreen actives’ approval, so the update “marks an important step in the effort to provide better sun safety for US consumers”, Julia Wray , a Freelance Beauty Editor who specialises in packaging, ingredients and formulation, told Cosmetics Business . Not yet a Subscriber ? This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business.
- Ingredient signalCoverage centres on sunscreen, pay attention to concentration, vehicle, and pairings in your routine before changing anything material.
- Protocol implicationIf you actively address rough, this is a data point worth logging, not a directive to change the protocol on its own.
Sunscreen use and the prevention of photoaging: a 4.5-year randomized controlled trial
A 4.5-year RCT showed daily SPF 15 reduces skin aging by 24% measured objectively. There is no anti-aging serum with this evidence base. Daily SPF is the single highest-leverage intervention.
Sun protection factor and photoprotection: evidence-based recommendations
Daily SPF is the single most evidence-backed anti-aging step. A 4.5-year study found it reduces melanoma risk by 50% and visible photoaging by 24%. Mineral SPF is best for sensitive and acne-prone skin.
This intelligence brief synthesizes reporting from beauty and dermatology industry publications.
View source →